These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 28684781)

  • 1. Characterization of transcriptional modules related to fibrosing-NAFLD progression.
    Lou Y; Tian GY; Song Y; Liu YL; Chen YD; Shi JP; Yang J
    Sci Rep; 2017 Jul; 7(1):4748. PubMed ID: 28684781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray-based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease: A Protein-protein Interaction Network Analysis.
    Mahmoudi A; Butler AE; De Vincentis A; Jamialahmadi T; Sahebkar A
    Curr Med Chem; 2024; 31(23):3631-3652. PubMed ID: 37194229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional networks implicated in human nonalcoholic fatty liver disease.
    Ye H; Liu W
    Mol Genet Genomics; 2015 Oct; 290(5):1793-804. PubMed ID: 25851235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Regulators Driving the Transition in Nonalcoholic Fatty Liver Disease: a Stage-Based View.
    Lou Y; Chen YD; Sun FR; Shi JP; Song Y; Yang J
    Cell Physiol Biochem; 2017; 41(1):239-251. PubMed ID: 28214827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LUM is the hub gene of advanced fibrosis in nonalcoholic fatty liver disease patients.
    Chang Y; He J; Xiang X; Li H
    Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101435. PubMed ID: 32386798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis.
    Zhang JJ; Shen Y; Chen XY; Jiang ML; Yuan FH; Xie SL; Zhang J; Xu F
    Front Endocrinol (Lausanne); 2023; 14():1115890. PubMed ID: 37008925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Western Diet-Induced Nonalcoholic Fatty Liver Disease Mice Mimic the Key Transcriptomic Signatures Observed in Humans.
    Ishigure T; Sasase T; Tohma M; Uno K; Toriniwa Y; Saito T; Saigo Y; Edamura K; Miyajima K; Ohta T
    Physiol Res; 2024 Aug; 73(4):593-608. PubMed ID: 39264080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WGCNA-Based Identification of Hub Genes and Key Pathways Involved in Nonalcoholic Fatty Liver Disease.
    Zeng F; Shi M; Xiao H; Chi X
    Biomed Res Int; 2021; 2021():5633211. PubMed ID: 34938809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis.
    Chen W; Zhao W; Yang A; Xu A; Wang H; Cong M; Liu T; Wang P; You H
    Gene; 2017 Dec; 636():87-95. PubMed ID: 28919164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of autophagy-related signatures in nonalcoholic fatty liver disease and correlation with non-parenchymal cells of the liver.
    Chen K; Wei L; Yu S; He N; Zhang F
    Mol Omics; 2024 Aug; 20(7):469-482. PubMed ID: 38982979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colon cancer recurrence‑associated genes revealed by WGCNA co‑expression network analysis.
    Zhai X; Xue Q; Liu Q; Guo Y; Chen Z
    Mol Med Rep; 2017 Nov; 16(5):6499-6505. PubMed ID: 28901407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of hub genes and key pathways of dietary advanced glycation end products‑induced non‑alcoholic fatty liver disease by bioinformatics analysis and animal experiments.
    Wang J; Liu H; Xie G; Cai W; Xu J
    Mol Med Rep; 2020 Feb; 21(2):685-694. PubMed ID: 31974594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems-level organization of non-alcoholic fatty liver disease progression network.
    Shubham K; Vinay L; Vinod PK
    Mol Biosyst; 2017 Aug; 13(9):1898-1911. PubMed ID: 28745372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse Model.
    Allen J; Zhang J; Quickel MD; Kennett M; Patterson AD; Hankey-Giblin PA
    J Proteome Res; 2018 Sep; 17(9):3268-3280. PubMed ID: 30091925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Immune Landscape of Cirrhosis through Weighted Gene Co-expression Network Analysis.
    Zhuoma B; Yang C; Wang W; Ranhen Y
    Cell Mol Biol (Noisy-le-grand); 2023 Jun; 69(6):168-174. PubMed ID: 37605574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of transcriptomic signatures and crucial pathways involved in non-alcoholic steatohepatitis.
    He W; Huang C; Zhang X; Wang D; Chen Y; Zhao Y; Li X
    Endocrine; 2021 Jul; 73(1):52-64. PubMed ID: 33837926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics Analysis of Key Differentially Expressed Genes in Nonalcoholic Fatty Liver Disease Mice Models.
    Hou C; Feng W; Wei S; Wang Y; Xu X; Wei J; Ma Z; Du Y; Guo J; He Y; Kong F; Tang R; Zheng K
    Gene Expr; 2018 Dec; 19(1):25-35. PubMed ID: 30135001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional Regulation of Early Growth Response Gene-1 (EGR1) is Associated with Progression of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients with Insulin Resistance.
    Li Z; Yu P; Wu J; Tao F; Zhou J
    Med Sci Monit; 2019 Apr; 25():2293-3004. PubMed ID: 31013265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The macrophage-associated microRNA-4715-3p / Gasdermin D axis potentially indicates fibrosis progression in nonalcoholic fatty liver disease: evidence from transcriptome and biological data.
    Chen S; Cai X; Liu Y; Shen Y; Guillot A; Tacke F; Tang L; Liu H
    Bioengineered; 2022 May; 13(5):11740-11751. PubMed ID: 35521691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.